Impact of obesity progression or regression on the longitudinal assessment of fibrosing interstitial lung disease

Eur Respir J. 2024 Apr 18;63(4):2301864. doi: 10.1183/13993003.01864-2023. Print 2024 Apr.

Authors

Hadeel Alqurashi¹, Mathieu Marillier², Igor Neder-Serafini¹, Anne-Catherine Bernard², Onofre Moran-Mendoza¹, J Alberto Neder³

Affiliations

¹ Division of Respirology and Sleep Medicine, Kingston Health Science Center, Queen's University, Kingston, ON, Canada.
² HP2 Laboratory, INSERM U1300, Grenoble Alpes University, Grenoble, France.
³ Division of Respirology and Sleep Medicine, Kingston Health Science Center, Queen's University, Kingston, ON, Canada alberto.neder@queensu.ca.

PMID: 38514096
DOI: 10.1183/13993003.01864-2023

No abstract available

Publication types

Letter

MeSH terms

Disease Progression
Fibrosis
Humans
Idiopathic Pulmonary Fibrosis* / diagnosis
Idiopathic Pulmonary Fibrosis* / pathology
Lung / pathology
Lung Diseases, Interstitial* / diagnosis
Lung Diseases, Interstitial* / pathology
Obesity / complications